Ignite Creation Date:
2024-05-06 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03665545
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-12-27
First Post:
2018-09-01
Brief Title:
Pembrolizumab in Association With the IMA950Poly-ICLC for Relapsing Glioblastoma
Sponsor:
University Hospital Geneva
Organization:
University Hospital Geneva
Organization Data
Organization:
University Hospital Geneva
Class:
OTHER
Study ID:
IMA950-106CER 2018-00718
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Geneva
Lead Sponsor Class:
OTHER
Responsible Party:
Denis Migliorini
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Hospital Geneva
Old Name:
None
Old Organization:
None